Janus Henderson Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.8M | Buy |
|
|||||
|
2025
Q2 | $628K | Sell |
|
|||||
|
2025
Q1 | $851K | Hold |
|
|||||
|
2024
Q4 | $783K | Sell |
|
|||||
|
2024
Q3 | $987K | Hold |
|
|||||
|
2024
Q2 | $1.16M | Sell |
|
|||||
|
2024
Q1 | $60.8M | Sell |
|
|||||
|
2023
Q4 | $269M | Sell |
|
|||||
|
2023
Q3 | $303M | Buy |
|
|||||
|
2023
Q2 | $294M | Sell |
|
|||||
|
2023
Q1 | $334M | Sell |
|
|||||
|
2022
Q4 | $402M | Sell |
|
|||||
|
2022
Q3 | $700M | Buy |
|
|||||
|
2022
Q2 | $348M | Sell |
|
|||||
|
2022
Q1 | $336M | Buy |
|
|||||
|
2021
Q4 | $344M | Sell |
|
|||||
|
2021
Q3 | $305M | Sell |
|
|||||
|
2021
Q2 | $330M | Sell |
|
|||||
|
2021
Q1 | $377M | Sell |
|
|||||
|
2020
Q4 | $499M | Buy |
|
|||||
|
2020
Q3 | $397M | Buy |
|
|||||
|
2020
Q2 | $197M | Buy |
|
|||||
|
2020
Q1 | $95.7M | Buy |
|
|||||
|
2019
Q4 | $4.51M | Sell |
|
|||||
|
2019
Q3 | $3.7M | Sell |
|
|||||
|
2019
Q2 | $4.76M | Buy |
|
|||||
|
2019
Q1 | $4.05M | Buy |
|
|||||
|
2018
Q4 | $3.82M | Sell |
|
|||||
|
2018
Q3 | $4.37M | Buy |
|
|||||
|
2018
Q2 | $4.19M | Hold |
|
|||||
|
2018
Q1 | $3.61M | Hold |
|
|||||
|
2017
Q4 | $3.97M | Hold |
|
|||||
|
2017
Q3 | $4.14M | Buy |
|
|||||
|
2017
Q2 | $3.01M | Buy |
|
|||||
|
2017
Q1 | $1.95M | Hold |
|
|||||
|
2016
Q4 | $1.84M | Buy |
|
|||||
|
2016
Q3 | $1.81M | Hold |
|
|||||
|
2016
Q2 | $1.52M | Hold |
|
|||||
|
2016
Q1 | $1.62M | Hold |
|
|||||
|
2015
Q4 | $2.05M | Hold |
|
|||||
|
2015
Q3 | $2.06M | Hold |
|
|||||
|
2015
Q2 | $2.68M | Hold |
|
|||||
|
2015
Q1 | $2.44M | Buy |
|
|||||
|
2014
Q4 | $1.64M | Hold |
|
|||||
|
2014
Q3 | $1.3M | Hold |
|
|||||
|
2014
Q2 | $1.13M | Hold |
|
|||||
|
2014
Q1 | $1.23M | Buy |
|
|||||
|
2013
Q4 | $614K | Hold |
|
|||||
|
2013
Q3 | $631K | Hold |
|
|||||
|
2013
Q2 | $519K | Buy |
|